Drinking one 12-oz sugary drink daily increases your risk of diabetes and cardiovascular disease by 20-25% and childhood obesity by 50-60%.
Stevia, also referred to as sweetleaf or sugarleaf, is a natural sweetener... a zero-calorie alternative to sugar that may help reduce these terrifying statistics.
Stevia does carry with it some general concerns. One of the main concerns is the bitter aftertaste. However, the next generation of Stevia sweeteners are already being developed, which will significantly reduce or completely eliminate this bitterness.
This process will allow mainstream companies to use Stevia in their products, and as a result, reduce calories from sugar by 85-90%.
Stevia has a zero glycemic load which makes it safe for diabetics.
Avoiding sugar and sugary drinks can help reduce your health risks significantly. Educating yourself and your loved ones about natural sweeteners is important and will make a positive impact on your health.
CEO of Stevia First, Robert Brooke, joins Andrea and Lisa to discuss the benefits of using an all-natural sweetener.
Wednesday, 26 February 2014 11:22
Satisfy Your Sweet Tooth with Stevia
Natural sweeteners such as Stevia can make a significant positive impact on your health.
Additional Info
- Segment Number: 3
- Audio File: naturally_savvy/1409ns3c.mp3
- Featured Speaker: Robert Brooke
- Guest Website: Stevia First Corporation
- Guest Facebook Account: https://www.facebook.com/SteviaFirstCorporation
- Guest Twitter Account: @SteviaFirstCorp
- Guest Bio: Robert Brooke is a co-founder of Stevia First Corp. He was previously the founder of Genesis Biopharma, Inc., a cancer drug development company, and served as President and CEO of Genesis until February 2011. Mr. Brooke also founded Percipio Biosciences, Inc., a research diagnostics company that manufactures and distributes products related to oxidative stress research worldwide. From 2004 to 2008, he was a buy-side analyst with Bristol Capital Advisors, LLC, an investment manager for Bristol Investment Fund, Ltd. During this period, Mr. Brooke helped finance more than 60 public healthcare and life science companies, and Bristol was listed by The PIPEs Report as the most active investor in private placements by public biotechnology companies. He earned a B.S. in Electrical Engineering from Georgia Tech in 2003 and a M.S. in Biomedical Engineering from UCLA in 2005.
- Length (mins): 10
- Waiver Received: Yes
- Host: Andrea Donsky, RHN and Lisa Davis, MPH
Published in
Naturally Savvy